EUVIMEDEUVIMED entdecken
Crossref

Cancer decentralized clinical trials in the Veterans Health Administration

Daphne R Friedman iD, Shannon L Elam iD, Sarah Bloemers, Zachary Burningham iD, Jacqueline Boreland iD, Ashlyn M Press iD, Jennifer Ordman, Crystal Okeke, Jo Martinez, Tiffany Stewart, Shelby Schoenborn, Perri Pepperman und 3 weitere

JNCI: Journal of the National Cancer Institute · 2026

DOI: 10.1093/jnci/djaf279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2026. Verfasst von Daphne R Friedman und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Oncology Program, US Department of Veterans Affairs, Washington, DC, United States. Hauptthemen laut MEDLINE: Neoplasms, United States Department of Veterans Affairs, Clinical Trials as Topic, Patient Selection. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Oncology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the importance of clinical trials in the advancement of cancer treatments, there are barriers to participant enrollment. Decentralized clinical trials are conducted at a different physical location than where patients receive medical care and can address patient-level and institution-level barriers that affect participant enrollment.

Methods

The Veterans Health Administration (VA) created a cancer-focused decentralized clinical trial program with a dedicated research team, operational manual, and other standardized operational protocols to support trial conduct. The decentralized clinical trial program works closely with the VA Office of Research & Development and VA central institutional review board.

Results

Ten cancer decentralized clinical trials have been implemented: 2 observational, 5 nontherapeutic interventional, and 3 therapeutic interventional. Eight were implemented as fully remote decentralized clinical trials, and 2 were hybrid decentralized clinical trials, with hybrid requiring collaboration with local clinicians for nonresearch activities. Across 47 VA medical centers, 134 Veterans enrolled: 31 (23%) in observational, 99 (74%) in nontherapeutic interventional, and 4 (3%) in therapeutic interventional decentralized clinical trials. Demographic characteristics of enrolled participants mirrored that of Veterans receiving cancer care through the VA’s National TeleOncology service, including rurality (31%) and non-White minority status (19%). Examples of the methods for research conduct that have been used across these decentralized clinical trials are included.

Conclusions

Cancer decentralized clinical trials can address barriers to participant enrollment, but not every clinical trial can be conducted in a decentralized manner. By sharing experiences regarding the conduct of cancer decentralized clinical trials in the VA, research sponsors, regulatory authorities, and other research groups can more readily and widely implement these trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsUnited States Department of Veterans AffairsClinical Trials as TopicPatient SelectionHumansUnited StatesResearch Design

Autor:innen und Institutionen

  • National Oncology Program, US Department of Veterans Affairs, Washington, DC, United States.
  • Medicine Service, Durham VA Health Care System, Durham, NC, United States.
  • Department of Medicine, Duke University School of Medicine, Durham, NC, United States.
  • IBM, Armonk, NY, United States.
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, United States.
  • Division of Epidemiology, University of Utah, Salt Lake City, UT, United States.

ORCID-Profile: Daphne R Friedman, Shannon L Elam, Zachary Burningham, Jacqueline Boreland, Ashlyn M Press, Michael J Kelley

Förderung

  • National Oncology Program

Zitieren

APA

Friedman, D. R., Elam, S. L., Bloemers, S., Burningham, Z., Boreland, J., Press, A. M., Ordman, J., Okeke, C., Martinez, J., Stewart, T., Schoenborn, S., Pepperman, P., Morris, H., Oberg, B., & Kelley, M. J. (2026). Cancer decentralized clinical trials in the Veterans Health Administration. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf279

Vancouver

Friedman DR, Elam SL, Bloemers S, Burningham Z, Boreland J, Press AM, et al. Cancer decentralized clinical trials in the Veterans Health Administration. JNCI: Journal of the National Cancer Institute. 2026. doi:10.1093/jnci/djaf279

BibTeX
@article{Friedman2026,
  author = {Friedman, Daphne R and Elam, Shannon L and Bloemers, Sarah and Burningham, Zachary and Boreland, Jacqueline and Press, Ashlyn M and Ordman, Jennifer and Okeke, Crystal and Martinez, Jo and Stewart, Tiffany and Schoenborn, Shelby and Pepperman, Perri and Morris, Holly and Oberg, Bethany and Kelley, Michael J},
  title = {Cancer decentralized clinical trials in the Veterans Health Administration},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2026},
  doi = {10.1093/jnci/djaf279}
}
Kostenlos starten →